From the vaccines that eradicated small pox and polio to the drugs that have improved cancer and AIDS treatment, the pharmaceutical industry is one of the great success stories in recent history. But as healthcare systems teeter out of balance, so does pharmaceuticals. With budgets rising and sales flattening, drug companies face a choice—whether to play in ever-smaller niches or reassert their position as key partners in improving global healthcare outcomes.